Medochemie Limited (Cyprus) is currently the only EU supplier with an EU Marketing Authorisation supplying Praziquantel 600mg tablets.
Praziquantel was approved in the EU many decades ago and has been marketed but current availability is highly constrained due to supply shortages and product discontinuation. The originator manufacturer, following an advance warning issued to the European Authorities, has stopped manufacturing the product, leading to a gradual pan-European shortage.
Medochemie is proud
